Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant

Clinical trial NCT00737113 · TERMINATED

Trial details

NCT number

NCT00737113

Sponsor

Mitchell Horwitz, MD

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2008-09-01

Primary completion

2012-05-01

Enrollment

14

View on ClinicalTrials.gov